
Global Markets React to Strong U.S. Jobs Data and Rising Yields
Jan 14, 2025 02:19 am UTC| Economy Business Research & Analysis
Global markets tumbled Monday following a robust U.S. jobs report that pushed Treasury yields to 14-month highs, challenging equity valuations as earnings season begins. European futures dipped, with EUROSTOXX 50 down 0.3%...

TSMC to Report 58% Surge in Q4 Profit Amid AI Demand Boom
Jan 14, 2025 02:16 am UTC| Business Fintech
Taiwan Semiconductor Manufacturing Co. (TSMC), the leading global producer of advanced chips powering artificial intelligence (AI) applications, is expected to announce a 58% jump in fourth-quarter profit. Analysts...

Taiwanese Chip Stocks Surge Amid AI Boom, TSMC Earnings in Focus
Jan 14, 2025 02:14 am UTC| Technology Economy Business
Taiwanese chipmakers reported strong revenues in Q4 2024, fueled by rapid advancements in artificial intelligence (AI). Major players like TSMC (TW:2330), MediaTek Inc (TW:2454), ASE Industrial Holding Co Ltd (TW:3711),...

Blue Origin's New Glenn Rocket Ready for Inaugural Launch
Jan 14, 2025 02:14 am UTC| Technology Business
Blue Origin is set to launch its New Glenn rocket, marking a significant milestone in its mission to rival SpaceX in the satellite launch market. The 30-story partially reusable rocket is scheduled for liftoff at 1:30 am...

AI Stocks Weekly: Key Analyst Moves on Tesla, AMD, Salesforce, and More
Jan 13, 2025 05:33 am UTC| Economy Technology Business
This week saw significant analyst updates on AI-related stocks, focusing on Tesla, AMD, Salesforce, and Adobe. Tesla Downgraded on Execution Risks Bank of America downgraded Tesla (NASDAQ:TSLA) to Neutral, citing execution...

Goldman Sachs Revises Fed Rate Cut Projections Amid Economic Concerns
Jan 13, 2025 05:32 am UTC| Economy Business
Goldman Sachs now forecasts the Federal Reserve will cut interest rates twice in 2025, compared to its earlier estimate of three cuts, citing persistent inflation and a robust labor market. The anticipated cuts are...

Johnson & Johnson Eyes $10 Billion Biopharma Deal with Intra-Cellular Therapies
Jan 13, 2025 05:25 am UTC| Business Health
Johnson Johnson is reportedly exploring the acquisition of biopharmaceutical company Intra-Cellular Therapies, according to Bloomberg News. The potential deal, valued at approximately $10 billion, could be finalized as...